The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Antibodies, Bispecific; Follow-Up Studies; Adult; Aged; Middle Aged; Female; Male; Antineoplastic Agents, Immunological
PubMed ID
38547425
PubMed Central ID
PMC11210942
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal